Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Clinical Oncology

• Publication date

  2013-03-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2012.44.3184PMID 23382473PMCID PMC3595425
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia

  2012cited by this paper
• Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia.

  2012cited by this paper
• Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia.

  2012cited by this paper
• Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia.

  2012cited by this paper
• Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML.

  2012cited by this paper
• TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome.

  2012cited by this paper
• Diagnostic and prognostic value of cytogenetics in acute myeloid leukemia.

  2011cited by this paper
• ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.

  2011cited by this paper
• Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markers.

  2011cited by this paper
• Independent prognostic variables in acute myeloid leukaemia.

  2011cited by this paper
• Gene expression profiling in MDS and AML: potential and future avenues

  2011cited by this paper
• Predictive value of TP53 fluorescence in situ hybridization in cytogenetic subgroups of acute myeloid leukemia

  2011cited by this paper
• Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications.

  2011cited by this paper
• Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system.

  2011cited by this paper
• Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association

  2011cited by this paper
• TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.

  2011cited by this paper
• Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome.

  2010cited by this paper
• Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B

  2009cited by this paper
• TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis

  2009cited by this paper
• Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling

  2009cited by this paper
• The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia

  2009cited by this paper
• Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.

  2008cited by this paper
• MicroRNA expression in cytogenetically normal acute myeloid leukemia.

  2008cited by this paper
• An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia.

  2008cited by this paper
• The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia.

  2008cited by this paper
• Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

  2008cited by this paper
• Assessment of survival prediction models based on microarray data

  2007cited by this paper
• Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

  2006cited by this paper
• Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.

  2006cited by this paper
• Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study.

  2006cited by this paper
• Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia.

  2005cited by this paper
• Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance.

  2005cited by this paper
• Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics

  2005cited by this paper
• Gene expression profiling in acute myeloid leukemia.

  2005cited by this paper
• Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.

  2005cited by this paper
• Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype.

  2005cited by this paper
• Prognostically useful gene-expression profiles in acute myeloid leukemia.

  2004cited by this paper
• Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia.

  2004cited by this paper
• Gene expression profiling of pediatric acute myelogenous leukemia.

  2004cited by this paper
• CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations.

  2004cited by this paper
• A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy.

  2004cited by this paper
• Profiling in acute leukemia.

  2003cited by this paper
• Identification of a gene expression signature associated with pediatric AML prognosis.

  2003cited by this paper
• MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

  2002cited by this paper
• Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).

  2002cited by this paper
• Articles on similar topics can be found in the following Blood collections

  2002cited by this paper
• Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles

  2002cited by this paper
• A Paradigm for Class Prediction Using Gene Expression Profiles

  2002cited by this paper
• Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

  2002cited by this paper
• Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.

  2002cited by this paper
• Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.

  2001cited by this paper
• Acute myeloid leukemia.

  1999cited by this paper
• Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.

  1999cited by this paper
• A stagewise rejective multiple test procedure based on a modified Bonferroni test

  1988cited by this paper
• Adjustment during army life

  1977cited by this paper
• VERIFICATION OF FORECASTS EXPRESSED IN TERMS OF PROBABILITY

  1950cited by this paper
• CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Global approach to the diagnosis of leukemia using gene expression profiling

  year unknowncited by this paper

• Upregulation of Genetic Markers of Poor Prognosis following Chemotherapy in Acute Myeloid Leukemia Cells

  2026cites this paper
• Study on the Role of Neutrophil Extracellular Traps-Based Risk Model and Discriminative Gene LTF in the Prognosis of Acute Myeloid Leukemia and the Regulation of Immune Microenvironment

  2026cites this paper
• ARL6IP5 in cancers: bidirectional function and therapeutic value

  2025cites this paper
• Development and validation of a disulfidptosis-related genes signature for predicting outcomes and immunotherapy in acute myeloid leukemia

  2025cites this paper
• Large-scale screens identify a 19-Gene MitoScore for improved risk assessment in acute myeloid leukemia.

  2025cites this paper
• Classification of acute myeloid leukemia based on multi‐omics and prognosis prediction value

  2025cites this paper
• Literature-Guided 6-Gene Signature for the Stratification of High-Risk Acute Myeloid Leukemia

  2025cites this paper
• The role of SLC22A4 in Acute Myeloid Leukaemia

  2025cites this paper
• Ubiquitin-specific protease 34 serves as a novel prognostic biomarker through correlating with immune responses and cell proliferation in acute myeloid leukemia

  2025cites this paper
• Neutrophil-Related Genes Predict Prognosis and Contribute to Immunosuppression in Acute Myeloid Leukemia

  2025cites this paper
• Loss of BAP1 defines a unique subtype of TP53-mutated de novo AML and confers sensitivity to BCL-xL inhibitors.

  2025cites this paper
• Integrative multi-omic analysis of NLRP3 inflammasome dysregulation and subtyping for personalized treatment in acute myeloid leukemia

  2025cites this paper
• The joint role of the immune microenvironment and N7-methylguanosine for prognosis prediction and targeted therapy in acute myeloid leukemia

  2025cites this paper
• Single-cell analysis defines highly specific leukemia-induced neutrophils and links MMP8 expression to recruitment of tumor associated neutrophils during FGFR1 driven leukemogenesis

  2024cites this paper
• A 4‐gene prognostic index for enhancing acute myeloid leukaemia survival prediction

  2024cites this paper
• T cell-mediated tumor killing sensitivity gene signature-based prognostic score for acute myeloid leukemia

  2024cites this paper
• Identification of hub genes and potential molecular mechanisms related to drug sensitivity in acute myeloid leukemia based on machine learning

  2024cites this paper
• Penalized Bayesian forward continuation ratio model with application to high-dimensional data with discrete survival outcomes

  2024cites this paper
• Comprehensive pan-cancer analysis identifies the RNA-binding protein LRPPRC as a novel prognostic and immune biomarker.

  2024cites this paper
• Development and validation of a cuproptosis-related prognostic model for acute myeloid leukemia patients using machine learning with stacking

  2024cites this paper
• SLC25A51 decouples the mitochondrial NAD+/NADH ratio to control proliferation of AML cells.

  2024cites this paper
• Improving risk stratification for 2022 European LeukemiaNet favorable-risk patients with acute myeloid leukemia

  2024cites this paper
• Characterization of ligand-receptor pair in acute myeloid leukemia: a scoring model for prognosis, therapeutic response, and T cell dysfunction

  2024cites this paper
• The Proteasome-Family-Members-Based Prognostic Model Improves the Risk Classification for Adult Acute Myeloid Leukemia

  2024cites this paper
• A CD8+ T cell related immune score predicts survival and refines the risk assessment in acute myeloid leukemia

  2024cites this paper
• Integrative single-cell analysis of longitudinal t(8;21) AML reveals heterogeneous immune cell infiltration and prognostic signatures

  2024cites this paper
• High temporal resolution prediction of mortality risk for single AML patient via deep learning

  2024cites this paper
• NAD metabolism-related genes provide prognostic value and potential therapeutic insights for acute myeloid leukemia

  2024cites this paper
• A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML

  2024cites this paper
• Immunotherapy-relevance of a candidate prognostic score for Acute Myeloid Leukemia

  2024cites this paper
• Glucocorticoids paradoxically promote steroid resistance in B cell acute lymphoblastic leukemia through CXCR4/PLC signaling

  2024cites this paper
• SMARCA5 reprograms AKR1B1-mediated fructose metabolism to control leukemogenesis.

  2024cites this paper
• Lysosome-related genes predict acute myeloid leukemia prognosis and response to immunotherapy

  2024cites this paper
• Comprehensive analysis of the RSK gene family in acute myeloid leukemia determines a prognostic signature for the prediction of clinical prognosis and treatment responses

  2023cites this paper
• Comprehensive characterization of TGFB1 across hematological malignancies

  2023cites this paper
• ATP1A1/BCL2L1 predicts the response of myelomonocytic and monocytic acute myeloid leukemia to cardiac glycosides

  2023cites this paper
• Preleukemic single-cell landscapes reveal mutation-specific mechanisms and gene programs predictive of AML patient outcomes

  2023cites this paper
• Pan-cancer analysis revealing that PTPN2 is an indicator of risk stratification for acute myeloid leukemia

  2023cites this paper
• Diagnosis of acute myeloid leukaemia on microarray gene expression data using categorical gradient boosted trees

  2023cites this paper
• Endoplasmic reticulum stress-related signature predicts prognosis and immune infiltration analysis in acute myeloid leukemia

  2023cites this paper
• High Expression of Microtubule-associated Protein TBCB Predicts Adverse Outcome and Immunosuppression in Acute Myeloid Leukemia

  2023cites this paper
• Bioinformatics analysis of the endoplasmic reticulum stress-related prognostic model and immune cell infiltration in acute myeloid leukemia

  2023cites this paper
• A novel 5-gene prognostic signature to improve risk stratification of cytogenetically normal acute myeloid leukemia

  2023cites this paper
• Deregulated Gene Expression Profiles and Regulatory Networks in Adult and Pediatric RUNX1/RUNX1T1-Positive AML Patients

  2023cites this paper
• Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients

  2023cites this paper
• Transcriptionally imprinted glycomic signatures of acute myeloid leukemia

  2023cites this paper
• A 29‐gene signature associated with NOX2 discriminates acute myeloid leukemia prognosis and survival

  2022cites this paper
• Construction and Validation of a Novel Ferroptosis-Related Prognostic Model for Acute Myeloid Leukemia

  2022cites this paper
• The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients

  2022cites this paper
• Targeting EZH2 Promotes Chemosensitivity of BCL-2 Inhibitor through Suppressing PI3K and c-KIT Signaling in Acute Myeloid Leukemia

  2022cites this paper
• Survival prediction optimization of acute myeloid leukaemia based on T‐cell function‐related genes and plasma proteins

  2022cites this paper
• Unraveling the mystery: How bad is BAG3 in hematological malignancies?

  2022cites this paper
• Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia

  2022cites this paper
• An immunity and pyroptosis gene-pair signature predicts overall survival in acute myeloid leukemia

  2022cites this paper
• A truncated derivative of FGFR1 kinase cooperates with FLT3 and KIT to transform hematopoietic stem cells in syndromic and de novo AML

  2022cites this paper
• Large-Scale In Vitro and In Vivo CRISPR-Cas9 Knockout Screens Identify a 16-Gene Fitness Score for Improved Risk Assessment in Acute Myeloid Leukemia

  2022cites this paper
• SGAClust: Semi-supervised Graph Attraction Clustering of gene expression data

  2022cites this paper
• Development and Validation of an Individualized Metabolism-Related Prognostic Model for Adult Acute Myeloid Leukemia Patients

  2022cites this paper
• Pan‐cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia

  2022cites this paper
• Engineering amino acid uptake or catabolism promotes CAR T-cell adaption to the tumor environment

  2022cites this paper
• N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia

  2022cites this paper
• eRNAs Identify Immune Microenvironment Patterns and Provide a Novel Prognostic Tool in Acute Myeloid Leukemia

  2022cites this paper
• Novel Prognostic Signature for Acute Myeloid Leukemia: Bioinformatics Analysis of Combined CNV-Driven and Ferroptosis-Related Genes

  2022cites this paper
• Pan-cancer analysis of necroptosis-related gene signature for the identification of prognosis and immune significance

  2022cites this paper
• Lysosome-mediated chemoresistance in acute myeloid leukemia

  2022cites this paper
• A Prognostic Model for Acute Myeloid Leukemia Based on IL-2/STAT5 Pathway-Related Genes

  2022cites this paper
• Loss-of-function mutations in the histone methyltransferase EZH2 promote chemotherapy resistance in AML

  2021cites this paper
• Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia

  2021cites this paper
• IRAK1-regulated IFN-γ signaling induces MDSC to facilitate immune evasion in FGFR1-driven hematological malignancies

  2021cites this paper
• Cytotoxic Marine Alkaloid 3,10-Dibromofascaplysin Induces Apoptosis and Synergizes with Cytarabine Resulting in Leukemia Cell Death

  2021influential citation
• The establishment of a prognostic scoring model based on the new tumor immune microenvironment classification in acute myeloid leukemia

  2021cites this paper
• Prognostic Factors in AML

  2021cites this paper
• Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia.

  2021cites this paper
• A clinical prediction model identifies a subgroup with inferior survival within intermediate risk acute myeloid leukemia

  2021cites this paper
• Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature

  2021cites this paper
• R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis.

  2021cites this paper
• Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A

  2021cites this paper
• Precision Medicine Treatment in Acute Myeloid Leukemia Is Not a Dream

  2021cites this paper
• DNA methylation analysis improves the prognostication of acute myeloid leukemia

  2021cites this paper
• Personalized Survival Prediction of Patients With Acute Myeloblastic Leukemia Using Gene Expression Profiling

  2021cites this paper
• Independent component analysis based gene co-expression network inference (ICAnet) to decipher functional modules for better single-cell clustering and batch integration

  2021cites this paper
• Systematic Construction and Validation of a Metabolic Risk Model for Prognostic Prediction in Acute Myelogenous Leukemia

  2020cites this paper
• A 6-Membrane Protein Gene score for prognostic prediction of cytogenetically normal acute myeloid leukemia in multiple cohorts

  2020cites this paper
• Genome-wide identification of FHL1 as a powerful prognostic candidate and potential therapeutic target in acute myeloid leukaemia

  2020cites this paper
• High WBP5 expression correlates with elevation of HOX genes levels and is associated with inferior survival in patients with acute myeloid leukaemia

  2020cites this paper
• Development and validation of a 10‐gene prognostic signature for acute myeloid leukaemia

  2020cites this paper
• Single-cell RNA sequencing of t(8;21) acute myeloid leukemia for risk prediction

  2020influential citation
• Harnessing Gene Expression Profiles for the Identification of Ex Vivo Drug Response Genes in Pediatric Acute Myeloid Leukemia

  2020cites this paper
• Inhibition of the RUNX1-CBFβ transcription factor complex compromises mammary epithelial cell identity: a phenotype potentially stabilized by mitotic gene bookmarking

  2020cites this paper
• Prognostic alternative mRNA splicing signatures and associated splicing factors in acute myeloid leukemia

  2020cites this paper
• Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125

  2020cites this paper
• Effects of Alternative Splicing Events on Acute Myeloid Leukemia

  2020cites this paper
• A KDM4A-PAF1-mediated epigenomic network is essential for acute myeloid leukemia cell self-renewal and survival

  2020influential citation
• Development and validation of a prognostic model for adult patients with acute myeloid leukaemia

  2020cites this paper
• An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy

  2020cites this paper
• A parsimonious 3-gene signature predicts clinical outcomes in an acute myeloid leukemia multicohort study.

  2019cites this paper
• Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML.

  2019influential citation
• Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients

  2019cites this paper
• Chromatin-Based Classification of Genetically Heterogeneous AMLs into Two Distinct Subtypes with Diverse Stemness Phenotypes

  2019cites this paper
• The M2 macrophage marker CD206: a novel prognostic indicator for acute myeloid leukemia

  2019cites this paper